Comparative Effectiveness of Newer Tyrosine Kinase Inhibitors Versus Imatinib in the First-Line Treatment of Chronic-Phase Chronic Myeloid Leukemia Across Risk Groups: A Systematic Review and Meta-Analysis of Eight Randomized Trials-Reference-Cited by-同舟云学术

Comparative Effectiveness of Newer Tyrosine Kinase Inhibitors Versus Imatinib in the First-Line Treatment of Chronic-Phase Chronic Myeloid Leukemia Across Risk Groups: A Systematic Review and Meta-Analysis of Eight Randomized Trials

Published:2016-06 Issue:6 Volume:16 Page:e85-e94
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Yun Seongseok^ORCID,Vincelette Nicole D.,Segar Jennifer M.,Dong Yimin,Shen Yang,Kim Dong-Wook,Abraham Ivo

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference39 articles.

1. Chronic myeloid leukemia—advances in biology and new approaches to treatment;Goldman;N Engl J Med,2003

2. International randomized study of interferon vs. STI571 (IRIS) 8-year follow up: sustained survival and low risk for progression or events in patients with newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP) treated with imatinib;Deininger;Blood,2009

3. Improved survival in chronic myeloid leukemia since the introduction of imatinib therapy: a single-institution historical experience;Kantarjian;Blood,2012

4. Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl;Weisberg;Cancer Cell,2005

5. Overriding imatinib resistance with a novel ABL kinase inhibitor;Shah;Science,2004

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Male Fertility and Fatherhood in Chronic Myeloid Leukemia: Current Understanding and Future Perspectives;Cancers;2024-02-15

2. Anti-Leukemic Attributes of Natural Compounds Targeting Autophagy: A Closer Look into the Molecular Mechanisms;Nutrition and Cancer;2024-01-23

3. Predicting individual-specific cardiotoxicity responses induced by tyrosine kinase inhibitors;Frontiers in Pharmacology;2023-04-10

4. BH3 mimetics and TKI combined therapy for Chronic Myeloid Leukemia;Biochemical Journal;2023-01-31

5. Proven Cytomegalovirus Colitis Associated with Dasatinib Administration in Two Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients;Pediatric Gastroenterology, Hepatology & Nutrition;2023